Close

This is a StreetInsider.com Premium Only Page

Please sign-up to enjoy all the benefits of StreetInsider.com Premium or log-in if you're already a member.

Send to a Friend Font Size: Increase Decrease

Back to KZR Stock Lookup

(KZR) – Trader Talk

Jun 27, 2022 04:11 PM Kezar Life Sciences (KZR) Climbs 35% Following Positive Results from Phase 2 Trial Evaluating Zetomipzomib for Treatment of Patients with LN

Back to KZR Stock Lookup